Portfolio company
Cyrano Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
The company develops pharmaceutical therapies to restore the sense of smell and taste for patients suffering from long-term olfactory dysfunction.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Olfera
Olfera develops biopharmaceutical delivery solutions using an olfactory platform to transport drugs directly to the brain for patients with neurological conditions.
Halo Therapeutics
This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.
Ray Therapeutics
The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.
Akouos
The company develops gene therapies to restore, improve and preserve hearing for individuals with disabling sensorineural hearing loss.
Cirrus Therapeutics
This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.
Sensorion
This company develops gene therapies and small molecule drugs to restore, treat and prevent inner ear disorders for patients with hearing loss.
CamGene
This company develops RNA-based therapeutics using lipid nanoparticle technology to treat hearing loss for patients with cellular dysfunction or undergoing cochlear implant surgery.
CamGene Therapeutics
This biotechnology company develops RNA-based medicines and lipid nanoparticle delivery technologies to treat hearing loss for patients with cellular dysfunction or cochlear implants.